NCT04552054

Brief Summary

This study evaluates the viability and accuracy of preoperative mixed reality technique combined with three-dimensional printing navigational template guided localizing pulmonary small nodules.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
136

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2018

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

August 28, 2020

Completed
20 days until next milestone

First Posted

Study publicly available on registry

September 17, 2020

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

September 17, 2020

Status Verified

May 1, 2020

Enrollment Period

2.5 years

First QC Date

August 28, 2020

Last Update Submit

September 10, 2020

Conditions

Keywords

pulmonary nodulelocalizationthree-dimensional printingmixed reality

Outcome Measures

Primary Outcomes (1)

  • Puncture success rate of localization

    The deviations of less than 2 cm between the lesion and the injected site was defined as successful localization.

    During surgery

Secondary Outcomes (1)

  • Time of localization

    During surgery

Study Arms (2)

CT guided localization

ACTIVE COMPARATOR

Computerized Tomography(CT)-guided percutaneous lung puncture staining marker localization

Device: Computerized Tomography guided localization

MR+3D guided localization

EXPERIMENTAL

Mixed reality(MR)+3D printing-guided percutaneous lung puncture staining marker localization

Device: Mixed Reality+ 3D printing guided localization

Interventions

Researchers project a three-dimensional reconstructed image of the patient's chest through MR glasses, then overlay the virtual chest with the actual chest. Finally, researchers put the three-dimensional printing navigational template on the surface of the body to guide for percutaneous lung puncture localization.

MR+3D guided localization

CT-guided percutaneous lung puncture staining marker localization.

CT guided localization

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • a maximum target lung nodule (one or more) diameter ≤20 mm
  • a target nodule CTR \<0·25 or a minimum distance from the outer edge of the nodule to the nearest pleural surface \>10 mm if the target nodule CTR was \>0·25.
  • Plan to perform VATS lung wedge resection

You may not qualify if:

  • Inability to comply with research protocols or research procedures
  • Any unstable systemic disease (including active infections, uncontrolled high blood pressure, unstable angina, angina pectoris that has started within the last 3 months, congestive heart failure (≥ New York Heart Association \[NYHA\] Level II ), cardiac infarction (6 months before enrollment), severe arrhythmia requiring medication, liver, kidney or metabolic disease
  • Active bleeding; Inability to withstand lying flat; Inability to cooperate through breathing during puncture
  • Pregnant or lactating women
  • Other circumstances that the investigator believes are not suitable for enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guangdong Provincial People's Hospital

Guangzhou, Guangdong, 51000, China

RECRUITING

MeSH Terms

Conditions

Lung NeoplasmsSolitary Pulmonary NoduleMultiple Pulmonary Nodules

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Wen-Zhao Zhong, Ph.D

    Guangdong Provincial People's Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Wen-Zhao Zhong, Ph.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 28, 2020

First Posted

September 17, 2020

Study Start

May 1, 2018

Primary Completion

October 31, 2020

Study Completion

December 1, 2020

Last Updated

September 17, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations